Evoke Wealth, LLC Bristol Myers Squibb CO Transaction History

Evoke Wealth, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $2 - $1,767	-23 Reduced 1.43%	1,580 $112,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $1,016 - $1,119	14 Added 0.88%	1,603 $124,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $127,509 - $152,895	-2,074 Reduced 56.62%	1,589 $117,000
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $14,962 - $17,443	-279 Reduced 7.08%	3,663 $228,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $6,390 - $7,485	108 Added 2.82%	3,942 $235,000
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $7,305 - $7,955	118 Added 3.18%	3,834 $237,000
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $51,507 - $57,930	-868 Reduced 18.94%	3,716 $236,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $14,204 - $16,095	-246 Reduced 5.09%	4,584 $287,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $42,498 - $47,093	740 Added 18.09%	4,830 $291,000
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $712 - $833	13 Added 0.32%	4,090 $241,000
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $189,172 - $274,912	4,077 New	4,077 $227 Million
Q4 2019 Feb 07, 2020	SELL	$49.21 - $64.19 $162,934 - $212,533	-3,311 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $141,611 - $167,900	3,311 New	3,311 $168 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.